Private Capital Group, LLC Travere Therapeutics, Inc. Transaction History
Private Capital Group, LLC
- $133 Million
- Q2 2022
A detailed history of Private Capital Group, LLC transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Private Capital Group, LLC holds 475 shares of TVTX stock, worth $8,445. This represents 0.01% of its overall portfolio holdings.
Number of Shares
475
Previous 475
-0.0%
Holding current value
$8,445
Previous $12,000
-0.0%
% of portfolio
0.01%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding TVTX
# of Institutions
193Shares Held
84.6MCall Options Held
776KPut Options Held
900K-
Armistice Capital, LLC New York, NY7.65MShares$136 Million1.78% of portfolio
-
Black Rock Inc. New York, NY7.64MShares$136 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.9MShares$123 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD4.68MShares$83.3 Million2.23% of portfolio
-
Woodline Partners LP San Francisco, CA4.34MShares$77.2 Million0.55% of portfolio
About Travere Therapeutics, Inc.
- Ticker TVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,173,600
- Market Cap $1.14B
- Description
- Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...